September 2, 2020
A new study jointly conducted by digital chronic care management tool Omada and Evidation Health found that patients using Omada’s diabetes management program reduced their A1c level and average of 0.8 over the course of the clinical research.
The study included a total of 195 participants with Type 2 diabetes who had an average baseline A1c of 8.93%. Researchers reported that those participants...
July 1, 2020
Health data analytics company Evidation Health secured a $45 million Series D raise led by B Capital Group. New backers McKesson Ventures and Section 32 joined the round, as did prior backers Revelation Partners, Rethink Impact and SV Health Investors.
The San Mateo company combines real-life patient data collected through more than 100 different sources, such as Apple Health, Fitbit, Epic and...
June 4, 2020
This morning real-world behavioral data analysis company Evidation Health announced a research initiative that will analyze behavior and symptom data to develop an early warning algorithm for COVID-19.
Funded by the Biomedical Advanced Research and Development Authority (BARDA) and the Bill and Melinda Gates Foundation, the effort will work with 4YouandMe – a nonprofit that helps individuals...
March 19, 2020
Evidation Health, a technology company that generates insights from real-world behavioral data collected through devices, has kicked off a new effort to better understand individuals' health behaviors and concerns throughout the COVID-19 pandemic.
Yesterday the company announced that it has recruited 100,258 people living in the U.S. into a longitudinal survey through the Achievement app,...
February 25, 2020
Apple and Johnson & Johnson announced this morning the launch of their new digital health study exploring the impact of Apple’s devices and a study-specific engagement program on cardiovascular outcomes among the Medicare population.
First announced in early 2019, the Heartline Study — which also names Evidation Health as a collaborator — is now enrolling seniors aged 65 years or older who...
August 8, 2019
Sensors from consumer-grade devices like iPhones, Apple Watches, iPads and Beddit sleep monitors capture enough data to spot mild cognitive impairment or Alzheimer’s disease dementia, according to a new feasibility study conducted jointly by Apple, Eli Lilly and Company and Evidation Health researchers that was presented today at a research conference held in Anchorage, Alaska.
“Over the past few...
December 17, 2018
CVS Caremark and health data management company Sharecare last week announced the launch of a digital pharmacy savings card for under-covered individuals. Accessed through an app, the Sharecare Rx program will provide discounts on CVS Caremark network drugs as well as search for lower drug prices. The digital card will be accepted at more than 68,000 in-network pharmacies.
“Whether treating strep...
August 23, 2018
Evidation Health is teaming up with Tidepool to launch a connected device-powered study of nocturnal hypoglycemic events in people with Type 1 diabetes.
The research is novel in that connected devices — including Dexcom continuous glucose monitors, an Emfit sleep monitor, and a WHOOP activity tracker — will allow researchers to access data about overnight low blood sugar events that previously...
August 17, 2018
Deborah Kilpatrick has spent some time on the cutting edge of the healthcare industry — her decade-spanning career has included a director position at Guidant Corporation’s vascular intervention accelerator (now part of Boston Scientific) and the chief commercial officer role at genomic diagnostic company CardioDx.
Now serving as the CEO of Evidation Health, a company investigating how everyday...
July 31, 2018
San Mateo, California-based health data analytics company Evidation Health announced today that it has raised $30 million in Series C funding. In addition, the company has launched a new platform that marries smartphone, sensor, and medical data together for cohesive insights into patient behaviors and outcomes.
Evidation’s latest round was led by new backer SV Health Investors and returning...